Company Quick10K Filing
FDCTech
10-Q 2021-03-31 Filed 2021-05-12
10-K 2020-12-31 Filed 2021-03-03
10-Q 2020-09-30 Filed 2020-11-05
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-13
10-K 2019-12-31 Filed 2020-04-07
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-09-20
8-K 2021-02-03 Enter Agreement, Regulation FD, Exhibits

FDCTech Financials

FDCT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($)2018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash321,035,000239,214,000210,064,000136,725,00095,011,00065,553,000
Accounts Receivable76,826,000100,122,00037,155,00071,030,00040,078,00015,878,000
Inventory
PP&E
Assets814,990,000824,903,000788,717,000821,651,000805,059,000765,124,000
Accounts Payable5,256,0006,233,0005,500,0002,572,00000
Long-Term Debt
Liabilities1,129,266,0001,141,154,0001,160,034,0001,169,342,0001,184,269,0001,208,513,000
Stockholders' Equity-314,276,000-316,251,000-371,317,000-347,691,000-379,210,000-443,389,000
Income Statement ($)2018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue182,498,000136,813,000174,535,00092,267,00057,760,000
Cost of Revenue2,160,0002,160,00010,282,0009,562,00048,127,000
Gross Profit180,338,000134,653,000164,254,00082,705,0009,633,000
R&D
SG&A142,221,000121,646,000137,015,000101,798,00058,813,000
Tax002,572,000-2,572,0000
Net Income21,250,000-1,974,0009,677,000-31,519,000-64,180,000
Cash Flow ($)2018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-8,774,0001,778,00022,422,00025,147,000
Cash Investing-70,598,000-77,302,000-65,635,000-61,850,000
Cash Financing-2,449,0002,185,0001,499,0007,245,000